| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8758243 | European Journal of Internal Medicine | 2017 | 5 Pages |
Abstract
Procalcitonin, presepsin, CD64, suPAR, and sTREM-1 are the best evaluated biomarkers for diagnosis and prognostication of sepsis to date. All have limitations in differentiation between infected and non-infected patients with SIRS, and their future role in diagnosis needs to be evaluated. It is important to test utility, performance, and validity of future biomarkers before implementing them in routine clinical care.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Frederik Fruergaard Larsen, J. Asger Petersen,